NCT02258685 Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients. Status COMPLETED Phase N/A
NCT02252471 Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females Status COMPLETED Phase NA
NCT02251236 Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals Status COMPLETED Phase NA
NCT02249962 Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART Status COMPLETED Phase N/A
NCT02248558 Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing Status COMPLETED Phase NA
NCT02245022 Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study Status COMPLETED Phase PHASE2/PHASE3
NCT02242799 Dolutegravir Interactions With Artemisinin-based Combination Therapies Status COMPLETED Phase PHASE1
NCT02238327 Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes Status COMPLETED Phase N/A
NCT02237326 Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women Status COMPLETED Phase NA
NCT02235662 Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone Status COMPLETED Phase PHASE1
NCT02228044 Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment Status COMPLETED Phase NA
NCT02223390 Improving the Health of South African Women With Traumatic Stress in HIV Care (C0147) Status COMPLETED Phase NA
NCT02223130 Addressing Discrimination and Mistrust Among Black Men: Phase III Status COMPLETED Phase NA